Veterinary Therapeutics Market 2017 Global Technology, Trends, Segmentation, Growth, Consumption

In addition to this, fast approval on new products is also driving the therapeutic drugs segment. However, increasing number of restrictions on the use of antibiotics may offset the segment’s growth. Vaccines are also projected to gain popularity among other veterinary therapeutic products in the upcoming years. The rising need for treating diseases in animals is the major factor driving this segment. Among regions, North America is expected to lead the global veterinary therapeutics market.

Sample PDF [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-therapeutics-market-100138

Segmentation:

By Animal Type

• Companion
• Livestock

By Product Type

• Medicated Feed Additives
• Drugs
• Vaccine

By Distribution Channels

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores

By Route of Administration

• Oral
• Parenteral
• Topical

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/veterinary-therapeutics-market-100138

Increasing Access to Treatment for Companion Animals to Propel the Market

“The increasing research and development (R&D) activities in the veterinary therapeutics area will create ample opportunities for the market’s growth,” stated a lead analyst at Fortune Business Insights. “This has further resulted in the discovery of novel treatment and surgical capabilities for companion animals, which will positively impact the market’s growth,” he added. Also, the rising population across the world, combined with rising demand for food, will act as a chief growth driver of the global veterinary therapeutics market.

The Veterinary Therapeutics Market is projected to grow at a significant rate on account of rising demand for meat and meat products. Fortune Business Insights in its new report, titled “Veterinary Therapeutics Market Size, Share and Global Trend by Product Type (Drugs, Vaccines), Animal Type (Companion, Livestock), Route of Administration (Oral, Parenteral, Topical), Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores) and Geography Forecast till 2025” finds that the growing population across the world is positively impacting the market.

Order Complete [email protected] https://www.fortunebusinessinsights.com/checkout-page/100138

The region market was valued at US$ 11,124.6 Mn in the year 2017. The increasing adoption of veterinary products in this region is likely to create ample growth opportunities for the veterinary therapeutics market until 2025. Besides North America, Asia Pacific is anticipated to show considerable growth in response to growing demand for of vaccines and drugs in the region. Rising livestock population in countries such as China and India will drive the veterinary therapeutics and medicine in Asia Pacific.

Some of the Main Key Players Covered in the Report: 

• Merck Animal Health
• Zoetis Inc.
• Elanco
• Merial
• Bayer Pharmaceuticals
• Bayer
• Boehringer Ingelheim
• CEVA LogisticsVetoquinol S.A.
• IDEXX
• Virbac

More Trending Topics From Fortune Business [email protected]

Telehealth Market to Cross US$ 266.8 Bn by 2026; Recent Technological Advancements in Healthcare Equipment to Provide Impetus, Says Fortune Business Insights

Mass Spectrometer Market Expected to Rise at 7.8% CAGR; Agilent’s Launch of a Hybrid Spectrometer Delivering Highly Analytical Data to Boost Growth: Fortune Business Insights